N-substituted lactams useful as cholecystokinin antagonists

Details N-substituted lactams useful as cholecystokinin antagonists N-substituted lactams useful as cholecystokinin antagonists

1992-10-29

1994-05-24

Shah, Mukund J.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Heterocyclic carbon compounds containing a hetero ring...

514314, 514403, 514414, 514422, 514423, 514424, 544406, 546169, 5483625, 548467, 548517, 548518, 548531, 548537, 548550, 540364, C07D207273, C07D207277, A61K 3140

Patent

active

053148860

ABSTRACT:
This invention relates to novel N-substituted lactams having the following formula ##STR1## useful in the treatment and prevention of Cholecystokinin (CCK) related disorders of the gastrointestinal, central nervous and appetite regulatory systems of mammals.

REFERENCES:
patent: 3474093 (1969-10-01), McCaully et al.
patent: 4200572 (1980-04-01), Gleason et al.
patent: 4260743 (1981-04-01), Bose
patent: 4757068 (1988-07-01), Parsons
Bayer, et al. "Preparation and properties of mesoionic oxazolones," Chemical Abstract 73(15):77105c (1970).
J. A. Williams "Cholecystokinin: A Hormone and A Nerurotransmitter," Biomedical Research 3(2), 107-121, (1982).
M. Albus "Cholecystokinin," Prog. Neuro-Psycholpharmacol & Biol. Psychiat. 1988, vol. 12, pp. S5-S21.
U. Scheurer "Mechanism of Action of Cholecystokinin Octapeptide on Rat Antrum, Pylorus and Duodenum," Am. J. Physiol. 244 G266-G272, (1983).
E. Corazziari "Oral Administration of Loxiglumide (CCK Antagonist) Inhibits Postprandial Gallbladder Contraction Without Affecting Gastric Emptying," Digestive Diseases and Sciences, 35(1), pp. 50-54, (Jan. 1990).
R. Harvey "Effect of Cholecystokinin on Colonic Motility and Symptoms in Patients with Irritable-Bowel Syndrome," The Lancet, Saturday, Jan. 6, 1973, p. 7793.
C. Niederau "Caerulein-Induced Acute Necrotizing Pancreatitis in Mice: Protective Effects of Proglumide, Benzotript, and Secretin," Gastroenterology, 88, pp. 1192-1204 (1985).
P. L. Faris "Evidence for the Neuropeptide Cholecystokinin as an Antagonist of Opiate Analgesia," Science 219, pp. 310-312 (1983).
N. S. Baber "The Role of CCK, Caerulein, and CCK Antagonists in Nociception," Pain, 39, pp. 307-328, (1989).
G. P. Smith "Gut Hormone Hypothesis of Postprandial Satiety," Eating and Its Disorders, pp. 67-75 (1984).
S. Ravard "Cholecystokinin and Anxiety," Trends in Pharmacol. Sci., 11, pp. 271-273, (1990).
J. Crawley "Behavioral Analyses of Antagonists of the Peripheral and Central Effects of Cholecystokinin," Cholecystokinin Antagonists, pp. 243-262, (1988).
S. A. Watson "Effects of L-365,260, a Potent Gastrin Receptor Antagonist on the In Vitro Growth of Animal and Human Gastro-Intestinal Tumour Cells," Gut., 30, 1447, (1989).
B. Douglas "Modulation by CR-1409 (Loglumide), a Cholecystokinin Receptor Antagonist, of Trypsin Inhibitor-Enhanced Growth of Azaserine-Induced Putative Preneoplastic Lesions in Rat Pancreas," Cancer Research, 49, pp. 2438-2441, (1989).
D. S. Garvey "3 4-disubstituted gamma-lactam rings as conformationally constrained mimics of peptide derivatives containing aspartic acid or norleueine," Journal of Organic Chemistry, 55(3), pp. 936-940, (1990).
A. Malik "New Synthetic Routes to Amino Sugars and Sugar Amino Acids," Chemical Abstract, 112:7794b p. 767, (1990).

Affiliated with

Also associated with

Rating

N-substituted lactams useful as cholecystokinin antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with N-substituted lactams useful as cholecystokinin antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and N-substituted lactams useful as cholecystokinin antagonists will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1972827